Profile
QLGN VRTX REGN VRNA ARGX ALNY
Company Name Qualigen Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.43M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Kevin A. Richardson II Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
QLGN VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
QLGN VRTX REGN VRNA ARGX ALNY
Last Close $3.04 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $5.99 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.67 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -49.25 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 82.04 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
QLGN VRTX REGN VRNA ARGX ALNY
1 Month Return -16.48 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 60 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -21.45 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -15.56 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -27.79 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -21.24 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
QLGN VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
QLGN VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -16.62 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -72.97 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -18.6 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100.08 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.68 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -219.3 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.08 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -11.44 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -11.44 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 6247.39 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -219.3 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -1.03 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -0.12 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -0.12 32.86 16.23 -126.33 144.41 162.25
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.61
AARD Aardvark Therapeutics, Inc. Common Stock 13.48
ABCL AbCellera Biologics Inc. 3.22
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.48
ABPWW 0.0155
ABSI Absci Corporation 2.76
ABUS Arbutus Biopharma Corporation 4.05
ABVC ABVC BioPharma, Inc. 1.73
ABVX Abivax SA American Depositary Shares 119.78
ACAD ACADIA Pharmaceuticals Inc. 23.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.25
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.33
ACIU AC Immune SA 3.11
ETFs With Exposure to QLGN
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.9
VXF Vanguard Extended Market Index Fund 0 219.57
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 166.55
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 166.56
VEMPX Vanguard Extended Market Index InstlPlus 0 411.02
Unlock